Administration of red blood cells to critically ill patients is among the most frequent therapeutic interventions in ICU setting. Anaemia is caused not only by bleeding, but is frequently associated with severe sepsis accompanied with down regulation of erythropoietin production, functional iron deficiency and shorter red blood cells lifespan. Daily routine blood samplings further contribute to severity of anaemia. Results of experimental studies, case reports of Jehovah Witnesses and in healthy volunteers suggest that under normovolemic conditions patients with normál cardiovascular status can sustain very low haemoglobin concentrations. Results of several recent observational studies suggest that restrictive approach to RBC administration with lower transfusion threshold (haemoglobin of 70g/l) may be associated with better outcome and lower mortality. Higher threshold is required only in patients with severe co-morbidities, mostly in patients with unstable coronary artery disease and acute myocardial infarction (8O-9Og/l). The potential for adverse role of RBC older than 3 weeks is frequently discussed. Surprisingly, the results of recent studies did not confirm the negative influence of RBC stored over 3 weeks on the outcome. Serious post transfusion compli-cations might be associated with residuals of leukocytes and of plasma, lntroduction of RBC leukodepletion diminished the extent of adverse events associated with immunomodulation (TRIM). Next to severe haemolytic reactions caused by ABO incompatibility due to clerical errors, the most important adverse reaction to RBC is TRALI (transfusion-related acute lung injury). Contrary to ALI (acute lung injury), it is usually associated with better outcome. The future role of fresh whole blood transfusion with full coagulation activity in extensive injuries under extréme conditions obtained from pre-screened donors (walking blood banks) is finally discussed.

        Key words: red blood cell transfusion, anaemia, transfusion threshold, critically ill patients, erythropoietin, leukodepletion, TRALI, fresh whole blood.